C.O. Truxton, Inc. Issues Voluntary Nationwide Recall of Amitriptyline HCL Tablets, USP 50mg and Phenobarbital Tablets, USP 15mg, 30mg, 60mg, 100mg Due to Potential Label Mix-Up

PUBLISHED: May 8, 2017
Source: Food and Drug Administration
Relevant to: Hospice, Long Term Care, Hospital, Home Health, Ambulatory Care, Medical Office/Clinic

C.O. Truxton, Inc. is expanding their 04/21/2017 voluntary recall, as a precaution, to the consumer/user level of Amitriptyline HCL Tablets, USP 50mg and Phenobarbital Tablets, USP 15mg, 30mg, 60mg, 100mg Due to Potential Label Mix-Up. See the link below for product names, NDC Codes, Lot Numbers and Expiration Dates.

C.O. Truxton has not received any complaints for the products listed in their recall notice, however, due to the initial recall resulting from a label mix-up error, out of an abundance of caution, they are recalling all products that were repackaged into a Truxton Incorporated label.

For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please follow the link below.

Want to read the full alert and receive alert emails?

Browse Additional Alerts